Skip to content

A Prospective,Multicenter, Single blind, Randomized Controlled Trial on the safety and reliability of telesurgery robotic system on urology

A Prospective,Multicenter, Single blind, Randomized Controlled Trial on the safety and reliability of telesurgery robotic system on urology

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077721
Enrollment
Unknown
Registered
2023-11-17
Start date
2023-11-18
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diseases of the genitourinary system

Interventions

Telesurgery Trial Group:Using telesurgery technology to conduct robotic surgery
Local surgery control group:Utilizing local surgical robots for surgery

Sponsors

Department of Urology, The Third Center, Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-80, male or female; 2. Body Mass Index (BMI) between 18 and 30 Kg/m2; 3. Relevant indications for urological surgery; 4. Physiological condition suitable for laparoscopic surgery; 5. Willing to cooperate and complete study follow-up and related examinations; 6. Voluntarily signs the informed consent form

Exclusion criteria

Exclusion criteria: 1. Severe cardiovascular or circulatory diseases that are not tolerable for surgery; 2. Pregnant or lactating; 3. History of epilepsy or mental illness; 4. Severe allergies and suspected or confirmed alcohol or drug addiction; 5. Inability to understand study requirements or complete study follow-up schedule; 6. Subjects considered by the investigator to be unsuitable for this study.

Design outcomes

Primary

MeasureTime frame
success rate of surgery;

Secondary

MeasureTime frame
QoR-15 score;30-second chair-to-stand test;Postoperative hospitalization days in six week;Complications after surgery in 6 weeks; operative time;Intraoperative blood loss;Reoperation in 6 weeks after surgery;task load of doctor;Measurement indicators of telesurgery;Complication rate;Re-hospitalization rate;number of deaths;

Countries

China

Contacts

Public ContactXu Zhang

Chinese PLA General Hospital

xzhang@foxmail.com+86 137 9531 4196

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026